Cases 1 - 6 of 6
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2023cv00031
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. USV Private Limited
as 1:2022cv00387
Counter Defendant:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Counter Claimant:
USV Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2022cv00227
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. v. Aurobindo Pharma Limited et al
as 1:2022cv00037
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2021cv00712
Defendant:
MSN Pharmaceuticals Inc., MSN Life Sciences Private Limited and MSN Laboratories Private Limited
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2021cv00662
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Limited
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
